May 04, 2018
U.S. talks trade with China amid broader strategic disengagement
The Trump administration’s senior economic team just wrapped up talks in Beijing to address rising U.S.–China tensions. These talks appear to have amounted largely to an exchange of views, with China, unsurprisingly, evincing little willingness to immediately address the bilateral trade deficit with the United States or curb its mercantilist economic approach.
The bottom line: The inconclusive results should not obscure a new direction in U.S. relations with China: disengagement.
In retrospect, the end of the Obama administration may represent the high-water mark of U.S.-China ties.
- Beijing’s bilateral trade with Washington reached roughly $578 billion in 2016, up from around $116 billion in 2000, while Chinese annual direct investment in the United States over the same period surged from $68 million to more than $45 billion.
Read the Full Article at Axios
More from CNAS
-
Podcast
Defense / Indo-Pacific Security
Hellscape Taiwan: Drones, Deterrence, and the Future of Asymmetric DefenseStacie Pettyjohn joined the Irregular Warfare Podcast to examine how Taiwan could deter—or potentially defeat—a Chinese invasion by transforming the Taiwan Strait into an “unm...
By Stacie Pettyjohn
-
Video
Indo-Pacific Security / Energy, Economics & Security
Analysts Break Down Trump-Xi Meeting and Calls for Stability and CooperationFor perspective on President Trump's trip and the broader U.S.-China relationship, Geoff Bennett spoke with Myron Brilliant and Liza Tobin. Brilliant is at the DGA Group and i...
By Liza Tobin
-
Video
Indo-Pacific Security / Energy, Economics & Security
Rajdeep Sardesai Asks Big Question on US-ChinaThe debate on the Big Question, with Daniel Silverberg, adjunct senior fellow at the Center for a New American Security, explores whether Beijing holds the key to resolving th...
By Daniel Silverberg
-
China’s Pharmaceutical Weapon
Commentary
Until SAPIR is extended to biologically derived drugs, until the FDA clears the bovine pathway, and until at least one American-owned heparin manufacturer operates on US soil,...
By Jennifer Hendrixson White
